0

524604

ADLINE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ADLINE CHEM LAB LIMITED Share Price Today

Investment Returns

Over 1 Month 15.70% Over 3 Months -2.28% Over 6 Months 48.91% Over 1 Year -4.92%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ADLINE CHEM LAB LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 8.00
  • P/E Ratio (TTM) 342.50
  • Beta -0.62
  • Book Value / share -2.75
  • Return on equity 0.00%
  • EPS (TTM) 0.04
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.09
info icon alternate text

ADLINE CHEM LAB LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit -0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.17
EBITDA -0.07
Effective Tax Rate (%) 9.09
Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 14.28
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.07
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.05
Effective Tax Rate (%) 12.50
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 16.66
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.09
Net Profit 0.21
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.04
EBITDA 0.19
Effective Tax Rate (%) -31.25
Particulars MAR 2026 (Values in Cr)
Revenue 0.00
Operating Expense 0.32
Net Profit -0.28
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.48
EBITDA -0.14
Effective Tax Rate (%) 12.50
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.45
Net Profit -0.13
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.07
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.30
Net Profit -0.27
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.18
Effective Tax Rate (%) 10.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.88
Net Profit -4.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -7.24
EBITDA -4.14
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.74
Operating Expense 1.39
Net Profit 0.72
Net Profit Margin (%) 97.29
Earnings Per Share (EPS) 1.23
EBITDA 1.08
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -2.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -2.35
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.45
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.53
ROE % -10.55
ROCE % -7.40
Total Debt to Total Equity 0.83
EBITDA Margin -14.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.04
EBITDA Margin -3.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.07
Total Liabilities 0.07
Total Equity -1.49
Share Outstanding 0
Price to Book Ratio -5.20
Return on Assets (%) -175.09
Return on Capital (%) 2360.71
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.04
Total Liabilities 0.04
Total Equity -1.37
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -644.07
Return on Capital (%) 1998.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.06
Total Liabilities 0.06
Total Equity -1.56
Share Outstanding 0
Price to Book Ratio -2.01
Return on Assets (%) -6858.26
Return on Capital (%) 1806.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.87
Total Liabilities 4.87
Total Equity 2.64
Share Outstanding 0
Price to Book Ratio 1.45
Return on Assets (%) 14.72
Return on Capital (%) 18.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -0.15
Total Assets 5.63
Total Liabilities 5.63
Total Equity 1.93
Share Outstanding 0
Price to Book Ratio 1.55
Return on Assets (%) -22.77
Return on Capital (%) -28.96
Particulars MAR 2025 (Values in Cr)
Net Income -0.20
Cash from Operations -0.32
Cash from Investing 0.00
Cash from Financing 0.24
Net change in Cash 0.02
Free Cash Flow -0.32
Particulars MAR 2024 (Values in Cr)
Net Income -0.30
Cash from Operations -0.16
Cash from Investing 0.00
Cash from Financing 0.14
Net change in Cash -0.01
Free Cash Flow -0.16
Particulars MAR 2023 (Values in Cr)
Net Income -4.23
Cash from Operations 0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.01
Particulars MAR 2022 (Values in Cr)
Net Income 0.71
Cash from Operations 0.21
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow 0.21
Particulars MAR 2021 (Values in Cr)
Net Income -1.28
Cash from Operations -0.29
Cash from Investing 0.11
Cash from Financing -0.03
Net change in Cash -0.20
Free Cash Flow -0.28
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 14.15 1.65 262.39 23.12 38.85
BLISS GVS PHARMA LTD 419.15 33.91 3.71 4434.14 118.35 462.70
CIPLA LTD 1388.25 29.46 3.25 112149.13 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.00 15.04 2.46 1003.60 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2183.50 36.23 16.31 36989.81 2136.05 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 23.94 4.41 262.39 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 554.85 24.87 4.33 1604.11 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8383.40 109.49 24.01 20958.50 7630.00 10653.05
BLISS GVS PHARMA LTD 419.15 45.07 3.83 4434.14 118.35 462.70

ADLINE CHEM LAB LIMITED shareholding pattern

Holding
74.14%
25.85%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ADLINE CHEM LAB LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
13.70 4.98 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
13.70 PIVOT
First Support 13.70 First Resistance 13.70 Second Support 13.70 Second Resistance 13.70 Third Support 13.70 Third Resistance 13.70
RSI 58.91 ADX 52.58 MACD 0.00 Williams % R -37.63 Commodity Channel Index (CCI) 54.00
Date 2026-05-22 Week 100.00 Same Day 100.00 Month 100.00
1 Year -0.61 3 Year 0.15
Over 1 Month
15.70% down
Over 1 Year
-4.92% down
Over 3 Months
-2.28% down
Over 3 Years
32.04% down
Over 6 Months
48.91% down
Over 5 Years
20.69% down

ADLINE CHEM LAB LIMITED Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Adline Chem Lab Ltd?

Answer Field

Adline Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 13.70 as on May 22 2026 12:00 AM.

What is the Market Cap of Adline Chem Lab Ltd Share?

Answer Field

The market cap of Adline Chem Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 8.00 as on May 22 2026 12:00 AM.

What is the 52 Week High and Low of Adline Chem Lab Ltd?

Answer Field

The 52 Week High and Low of Adline Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.08 and ₹ 7.60.

What is 1 year return for Adline Chem Lab Ltd?

Answer Field

The 1 year returns on the stock has been -4.92%.

What is the P/E Ratio of Adline Chem Lab Ltd Share?

Answer Field

As on May 22 2026 12:00 AM the price-to-earnings (PE) ratio for Adline Chem Lab Ltd share is 342.50.

What is the PB ratio of Adline Chem Lab Ltd Share?

Answer Field

As on May 22 2026 12:00 AM, the price-to-book (PB) ratio for Adline Chem Lab Ltd share is -2.75.

How to Buy Adline Chem Lab Ltd Share?

Answer Field

You can trade in Adline Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Adline Chem Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Adline Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Adline Chem Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|